Phase I Trial of Ex Vivo Expanded Donor Gamma Delta T Cell Immunotherapy to Prevent Acute Myeloid Leukemia Relapse after Allogeneic TransplantationNelli Bejanyan, Marco L. Davila, Hany Elmariah et al.|Blood|2024Cited by 2
Phase I Trial of Ex Vivo Expanded Donor Gamma Delta T Cell Immunotherapy to Prevent Acute Myeloid Leukemia Relapse after Allogeneic TransplantationNelli Bejanyan, Marco L. Davila, Hany Elmariah et al.|Transplantation and Cellular Therapy|2025Cited by 1
Data from CD28 Costimulatory Domain–Targeted Mutations Enhance Chimeric Antigen Receptor T-cell FunctionJustin C. Boucher, Marco L. Davila, Kristen Spitler et al.|Unknown|2023Cited by 0